We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Getein Biotech, Inc.

Getein Biotech, Inc. is a fully integrated in vitro diagnostic company that develops, manufactures and distributes an... read more Featured Products: More products

Download Mobile App





Getein Biotech Exhibits Advanced POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2023

Getein Biotech, Inc. More...

(Nanjing, China) is exhibiting its range of advanced analyzers for point-of-care testing at MEDICA 2023.

At the MEDICA show, visitors to the Getein booth can experience its unique products and services first-hand that deliver efficient diagnostic and treatment solutions, helping healthcare professionals increase efficiency, reduce costs, and deliver a better patient experience. Getein is highlighting its Metis 6000 Modular System (Integrated Clinical Chemistry and Immunochemistry) that helps labs unlock efficiency and optimize space. The Metis 6000 Modular System comprises the MAGICL 6200 immunochemistry module with a throughput of up to 400 T/H, the CM-1000 clinical chemistry module with a throughput of up to 1000 T/H, and the SHC 200 pre-analytical module (optional) with a speed of 190 tubes/H.

Getein is also showcasing the Metis 600 Modular System (Integrated Immunofluorescence and Hematology) which provides a suitable solution for immunofluorescence and hematology testing in low-volume laboratories. The Metis 600 Modular System comprises the Getein 1200 immunofluorescence quantitative analyzer and the BHA-5100 automatic hematology analyzer. The combination of immunofluorescence and hematology methodologies allows for more comprehensive test items to be offered. Also on display at MEDICA 2023 is the BHA-5000 automatic 5-part differential hematology analyzer which uses laser-based flow cytometry to count white blood cells in blood samples. It also uses electrical impedance to count red blood cells and platelets, and colorimetry to measure the hemoglobin, and relevant parameters will be enumerated.

In addition, Getein is exhibiting the MAGICL 6000 chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that require a one-step chemiluminescence solution. Alongside MAGICL 6000 was the Getein 1600 fully-automated immunofluorescence quantitative analyzer which combined with bar-coded, ready-to-use strip cassettes, delivers accurate testing results in minutes. The company is demonstrating the Getein 208 hand-held integrated system which is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood, and urine samples through dry chemistry and fluorescence immunoassay. Visitors to the company’s booth can learn about Getein’s POCT test menu which includes a wide range of reagent options, covering rapid testing for various diseases and health indicators.

Related Links:
Getein Biotech, Inc. 


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Portable Electronic Pipette
Mini 96
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.